A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

NCT06997029 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Advanced Breast Cancer
Advanced Ovarian Cancer

Interventions

DRUG: BMS-986500
DRUG: Palbociclib
DRUG: Fulvestrant

Sponsor

Bristol-Myers Squibb